Marco Zimarino

Showing 1-3 of 3 articles

Impact of sex on comparative outcomes of bivalirudin versus unfractionated heparin in patients with acute coronary syndromes undergoing invasive management: a pre-specified analysis of the MATRIX trial

Gargiulo G, Pasquetto G, Brugaletta S, Ferrari F, Casu G, Guiducci V, Dellavalle A, Liistro F, Mauro C, van't Hof A, Omerovic E, Curello S, de la Torre Hernandez J, De Servi S, Belloni F, Windecker S, Penzo C, Colombo A, da Costa B, Frigoli E, Palmieri C, Nazzaro M, Falcone C, Liso A, Vigna C, Abate F, Comeglio M, Diletti R, Gabrielli G, Di Lorenzo E, Mazzarotto P, Zimarino M, Moretti C, Valgimigli M

June 12, 2019 | 10.4244/EIJ-D-18-00247

Coronary interventions

What about the risk of thrombosis with bioresorbable scaffolds?

Capodanno D, Joner M, Zimarino M

May 19, 2015 | 10.4244/EIJV11SVA43

Optical coherence tomography appraisal of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing intraprocedural versus post-stenting prolonged bivalirudin infusion. Rationale and design of the MATRIX (Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and angioX) OCT substudy

Picchi A, Limbruno U, Andò G, Brugaletta S, Cortese B, De Carlo M, Garcia-Garcia H, Palmieri C, Regar E, Rigattieri S, Sardella G, Zimarino M, Valgimigli M

March 20, 2015 | 10.4244/EIJY15M02_10

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke